EU
XLRN

Emory University’s Acceleron Pharma XLRN Stock Holding History

Emory University’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-45,445
Closed -$1.98M – 50
2018
Q4 		$1.98M Buy
+45,445
New +$2.27M 1.56% 23
2018
Q2 		– Sell
-62,410
Closed -$2.44M – 50
2018
Q1 		$2.44M Buy
+62,410
New +$2.65M 1.74% 23

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Emory University's XLRN Position: Q1 2019 in Review

Emory University sold out of Acceleron Pharma (XLRN) in Q1 2019, closing a stake of 45,445 shares — an estimated $1.98M sold.

Emory University first reported a position in XLRN in Q1 2018 and held it in 2 quarters. The position peaked at $2.44M in Q1 2018. 171 funds tracked by Wall St. Rank hold XLRN as of Q1 2019.

  • Emory University reported no remaining Acceleron Pharma position as of Q1 2019 after selling out during the quarter.
  • Emory University sold 45,445 Acceleron Pharma shares in Q1 2019, an estimated $1.98M.
  • Emory University first reported a position in Acceleron Pharma in Q1 2018 and held it in 2 quarters.
  • Emory University's Acceleron Pharma position peaked at $2.44M in Q1 2018.
  • 171 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2019.

Based on Emory University's 13F filing for Q1 2019, filed 9 May 2019.